查看购物车
  • Traditional Chinese
  • English
  • Japanese
罕见病医疗食品市场规模,份额和趋势分析报告：按给药途径,产品,应用（酪氨酸血症,MSUD,同型半胱氨酸尿症）,销售渠道,地区,细分市场预测2023~2030
市场调查报告书
商品编码
1170897

罕见病医疗食品市场规模,份额和趋势分析报告：按给药途径,产品,应用（酪氨酸血症,MSUD,同型半胱氨酸尿症）,销售渠道,地区,细分市场预测2023~2030

Medical Foods For Orphan Diseases Market Size, Share & Trends Analysis Report By Route Of Administration, By Product, By Application (Tyrosinemia, MSUD, Homocystinuria), By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

罕见病医疗食品市场的增长和趋势

到 2030 年，全球罕见病医疗食品市场预计将达到 19 亿美元。 根据 Grandview Research 的一份新报告，预计从 2022 年到 2030 年，它的复合年增长率将达到 5.5%。 促进该行业增长的主要因素是罕见病患病率上升以及人们对此类罕见病的认识不断提高。 此外，政府加大早期筛查力度，主要参与者加大力度开发产品以满足此类利基细分市场，也预示着良好的增长前景。

各种罕见疾病需要特殊的医学营养来预防严重残疾并使儿童和成人能够正常成长。 由食物蛋白质引起的枫糖浆尿病和短肠综合症等疾病需要特殊饮食以保持健康。 对这些罕见疾病的认识不断提高以及饮食治疗的有效性不断提高，预计将提供进一步的增长途径。

医疗食品价格昂贵，可能会或可能不会被健康保险覆盖。 由于 FDA 未将药用食品归类为药物，因此许多保险计划不涵盖药用食品。 这可能会阻碍预测期内的市场扩张。

与其他行业不同，COVID-19 对市场增长产生了积极影响。 免疫和健康食品意识的提高导致临床食品的采用率显着提高。 与 2019 年相比，2020 年消费者选择了更健康的饮食，包括营养支持和饮食。

到 2022 年，口腔部分以超过 69.5% 的收入份额占据市场主导地位。 药物食品的口服途径仍然是最方便和无忧的。 因此，它仍然是全球消费者最喜欢的途径，而且口服产品很容易买到。 扩大片剂、粉剂和增稠剂等形式的口服产品的生产也仍然是增长的主要驱动力。

到 2022 年，粉末业务将占最大的收入份额，超过 35.4%。 粉状药用食品的现成商业可用性一直是该细分市场增长的主要因素。 此外，易于使用的粉状产品受到患有各种罕见疾病的儿科和老年患者的广泛青睐，这继续推动了这一细分市场的扩张。

2022 年，设施销售渠道的收入份额最大，超过 41.2%。 这部分包括家庭护理场所、医院和残疾人设施。 预计在线销售部门将在预测期内以最快的速度扩张。 由于这些销售渠道提供的便利，越来越多的人选择在线购买药用食品。

罕见病医疗食品市场报告要点

2022 年的市场规模为 12 亿美元，预计 2022 年至 2030 年的复合年增长率为 5.5%。 罕见病患病率上升、医疗费用、早期筛查和对罕见病的认识是推动增长的关键因素

到 2022 年，口腔部分将占总销售额的 69.5% 以上。 然而，肠内给药领域预计在预测期内增长最快。 主要参与者高度关注技术先进的肠内餵养设备的开发，预计这些设备将在这一领域的增长中发挥重要作用。

2022 年，粉末业务的收入份额最大，超过 35.4%。 然而，预计液体部分将在预测期内以最快的复合年增长率增长。 由于有限或无法消费固体製剂，儿科和老年消费者越来越多地采用液体製剂是推动这一细分市场增长的主要原因。

到 2022 年，机构销售渠道将占最大收入份额，超过 41.2%。 越来越多的患者前往医院和其他医疗中心诊断和治疗各种罕见病，继续推动这一细分市场的增长

其他部门在 2022 年的收入份额最大，超过 36.5%。 越来越多的低过敏性产品的商业推出以及各种配方的此类产品的商业可用性进一步推动了这一细分市场的增长。 然而，预计 FPIES 州将在预测期内表现出最快的复合年增长率

2022 年，北美收入占比最大，超过 30.6%。 在预测期内，亚太地区预计将成为增长最快的区域市场。 渗透率的提高、意识的提高、医疗食品使用的增加以及政府的几项重大举措继续支撑着增长。

内容

第一章调查方法及范围

  • 市场细分和范围
  • 市场定义
  • 调查方法
    • 信息采购
      • 购买的数据库
      • GVR 内部数据库
    • 初步调查：
  • 调查范围和假设
  • 列表到数据源

第 2 章执行摘要

  • 市场展望
  • 细分市场展望
  • 竞争考虑
  • 全球罕见病医疗食品概览

第 3 章全球罕见病医疗食品市场变量、趋势和范围

  • 市场系列展望
    • 母公司的市场前景
    • 相关/子公司市场前景
  • 描绘渗透率和增长前景
  • 价格分析
  • 用户视角分析
    • 消费者行为分析
    • 市场影响者分析
  • 技术展望
    • 技术时间表
  • 监管框架
    • 报销框架
    • 标准与合规性
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
    • 行业问题
  • 罕见病医疗食品市场分析工具
    • 行业分析 - 搬运工
      • 供应商的力量
      • 买家的议价能力
      • 替代威胁
      • 来自新进入者的威胁
      • 竞争公司之间的敌对关係
    • PESTEL 分析
      • 政治形势
      • 环境状况
      • 社交情况
      • 技术概况
      • 法律状况
      • 经济状况
    • 对主要交易和战略联盟的分析
      • 併购
      • 许可和合作伙伴关係
    • 市场进入策略
  • COVID-19 对市场的影响

第4章罕见病医疗食品市场竞争分析

  • 主要市场进入者的近期趋势和影响分析
  • 竞争分类法
  • 公司市场分析
  • 主要公司的市场份额分析 (%)

第 5 章罕见病医疗食品市场：给药途径的估计和趋势分析

  • 定义和范围
  • 全球罕见病医疗食品市场：给药途径市场份额分析，2022 年和 2030 年
  • 口语
  • 肠内

第 6 章罕见病医疗食品市场：产品预测和趋势分析

  • 定义和范围
  • 全球罕见病医疗食品市场：产品市场份额分析，2022 年和 2030 年
  • 药丸
  • 粉末
  • 液体
  • 其他

第7章罕见病医疗食品市场：应用预估及趋势分析

  • 定义和范围
  • 全球罕见病医疗食品市场：应用市场份额分析，2022 年和 2030 年
  • 苯丙酮尿症
  • 嗜酸性粒细胞性食管炎
  • 狂欢
  • 酪氨酸血症
  • 密歇根大学
  • 同型半胱氨酸尿症
  • 其他

第 8 章罕见病医疗食品市场：销售渠道估计和趋势分析

  • 定义和范围
  • 全球罕见病医疗食品市场：2022 年和 2030 年分销渠道市场份额分析
  • 在线销售
  • 机构销售
  • 零售销售

第 9 章罕见病医疗食品市场：按地区、给药途径、产品、应用和销售渠道分类的估计和趋势分析

  • 全球罕见病医疗食品市场：区域差异分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 俄罗斯
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 新西兰
    • 新加坡
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 多边环境协定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国

第十章公司简介

  • DANONE
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • NESTLE
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • ABBOTT
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • MEAD JOHNSON &COMPANY, LLC
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Relief Therapeutics
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Solace Nutrition
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
  • Ajinomoto Cambrooke, Inc.
    • 公司简介
    • 财务业绩
    • 产品基准
    • 战略举措
Product Code: GVR-4-68039-993-4

Medical Foods For Orphan Diseases Market Growth & Trends:

The global medical foods for orphan diseases market size is expected to reach USD 1.9 billion by 2030. It is expected to expand at a CAGR of 5.5% from 2022 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to the industry's growth are the growing prevalence of orphan diseases and increasing awareness about such rare conditions. Moreover, rising government initiatives for early screening and increasing initiatives by key players to develop products that cater to such niche segments also spell a promising horizon of growth.

Special medical nutritional requirements are needed for a variety of rare diseases in order to prevent major disabilities and allow normal growth in children and adults. Conditions like food protein-induced maple syrup urine disease, short bowel syndrome, and others, require special dietary requirements in order to maintain robust health. The growing awareness of such rare conditions and increased efficacy of diet plans also promise more avenues for growth.

Medical foods are expensive and may or may not be covered under health insurance. Since the FDA does not classify medicinal foods as drugs, many insurance plans do not cover them. This can impede market expansion over the forecast period.

Unlike other industries, COVID-19 had a positive impact on market growth. The increased awareness about immunity and healthy foods led to a significant rise in the adoption rate of clinical foods. In the year 2020, consumers opted for much healthier diets encompassing nutritional support and dietetic care as compared to the year 2019.

The oral segment dominated the market with a revenue share of over 69.5% in 2022. The oral route for medicinal foods remains the most convenient, and hassle-free. Hence, it remains the most preferred route for consumers globally and oral products are easily available. The expanding production of oral goods in the form of tablets, powder, and pre-thickened products also remains a prominent driver of growth.

The powder segment accounted for the largest revenue share of over 35.4% in 2022. Easy commercial availability of medicinal foods in powdered form is largely responsible for the segment's expansion. Additionally, powered forms of products are simple to use and hence widely preferred by pediatric and geriatric patients suffering from various rare diseases, which continues to drive the segment's expansion.

The institutional sales channel accounted for the largest revenue share of over 41.2% in 2022. The segment includes home care settings, hospitals, and disability facilities. The online sales segment is anticipated to expand at the fastest rate over the forecast period. Due to the convenience, these sales channel provides, more people choose to buy medicinal foods online.

Medical Foods For Orphan Diseases Market Report Highlights:

  • The market size was valued at USD 1.2 billion in 2022 and is expected to grow at a CAGR of 5.5% from 2022 to 2030. Increasing prevalence of rare diseases, healthcare expenditure, early screening, and awareness about rare diseases are some key factors that propel the growth
  • The oral segment held the dominant revenue share of over 69.5% in 2022. However, the enteral route of the administration segment is expected to showcase the fastest growth over the forecast years. Key players are highly focused on developing technologically advanced enteral feeding devices which are anticipated to play a major role in this segment's growth.
  • The powder segment accounted for the largest revenue share of over 35.4% in 2022. However, the liquid segment is expected to grow at the fastest CAGR over the forecast period. The rising adoption rate of liquid formulations by pediatric and geriatric consumers, as the intake of solid formulations is restricted or unfeasible is the major reason that fuels the segment's growth
  • The institutional sales channel accounted for the largest revenue share of over 41.2% in 2022. The increasing number of patient visits to hospitals and other healthcare centers for the diagnosis and treatment of different orphan disorders continues to propel the growth of the segment
  • The others segment accounted for the largest revenue share of over 36.5% in 2022. The increasing number of hypoallergenic product launches and easy commercial availability of such products in various formulations further boost the segment's growth. However, FPIES condition is expected to showcase the fastest CAGR over the forecast period
  • In 2022, North America held the largest revenue share of over 30.6%. Asia Pacific is anticipated to be the fastest-growing regional market over the forecast period. Increasing penetration rate, awareness, growing use of medical foods, and several key government initiatives remain the cornerstone of its growth

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Market Definition
  • 1.3 Research Methodology
    • 1.3.1 Information Procurement
      • 1.3.1.1 Purchased database
      • 1.3.1.2 GVR's internal database
    • 1.3.2 Primary Research:
  • 1.4 Research Scope and Assumptions
  • 1.5 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights
  • 2.4 Global Medical Foods for Orphan Diseases Snapshot

Chapter 3 Global Medical Foods for Orphan Diseases Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Pricing Analysis
  • 3.4 User Perspective Analysis
    • 3.4.1 Consumer behavior analysis
    • 3.4.2 Market influencer analysis
  • 3.5 Technology Outlook
    • 3.5.1 Technology timeline
  • 3.6 Regulatory Framework
    • 3.6.1 Reimbursement framework
    • 3.6.2 Standards and compliances
  • 3.7 Market Dynamics
    • 3.7.1 Market driver analysis
    • 3.7.2 Market restraint analysis
    • 3.7.3. Industry Challenges
  • 3.8 Medical Foods for Orphan Diseases Market Analysis Tools
    • 3.8.1. Industry Analysis - Porter's
      • 3.8.1.1 Supplier power
      • 3.8.1.2 Buyer power
      • 3.8.1.3 Substitution threat
      • 3.8.1.4 Threat from new entrant
      • 3.8.1.5 Competitive rivalry
    • 3.8.2. PESTEL analysis
      • 3.8.2.1 Political landscape
      • 3.8.2.2 Environmental landscape
      • 3.8.2.3 Social landscape
      • 3.8.2.4 Technology landscape
      • 3.8.2.5 Legal landscape
      • 3.8.2.6 Economic landscape
    • 3.8.3 Major deals & strategic alliances analysis
      • 3.8.3.1 Mergers & acquisitions
      • 3.8.3.2 Licensing & partnership
    • 3.8.4 Market entry strategies
  • 3.9 COVID-19 Impact on the market

Chapter 4 Medical Foods for Orphan Diseases Market-Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 4.2 Competition Categorization
  • 4.3 Company Market Position Analysis
  • 4.4 Key Company Market Share Analysis (%)

Chapter 5 Medical Foods for Orphan Diseases Market: Route of Administration Estimates & Trend Analysis

  • 5.1 Definitions & Scope
  • 5.2 Global Medical Foods for Orphan Diseases Market: Route of Administration Market Share Analysis, 2022 and 2030
  • 5.3 Oral
    • 5.3.1 Oral market estimates and forecasts, 2016 - 2030 (USD Million)
  • 5.4 Enteral
    • 5.4.1 Enteral market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 6 Medical Foods for Orphan Diseases Market: Product Estimates & Trend Analysis

  • 6.1 Definitions & Scope
  • 6.2 Global Medical Foods for Orphan Diseases Market: Product Market Share Analysis, 2022 and 2030
  • 6.3 Pills
    • 6.3.1 Pills market estimates and forecasts, 2016 - 2030 (USD Million)
  • 6.4 Powders
    • 6.4.1 Powders market estimates and forecasts, 2016 - 2030 (USD Million)
  • 6.5 Liquid
    • 6.5.1 Liquid market estimates and forecasts, 2016 - 2030 (USD Million)
  • 6.6 Others
    • 6.6.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 7 Medical Foods for Orphan Diseases Market: Application Estimates & Trend Analysis

  • 7.1 Definitions & Scope
  • 7.2 Global Medical Foods for Orphan Diseases Market: Application Market Share Analysis, 2022 and 2030
  • 7.3 Phenylketonuria
    • 7.3.1 Phenylketonuria market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.4 Eosinophilic Esophagitis
    • 7.4.1 Eosinophilic Esophagitis market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.5 FPIES
    • 7.5.1 FPIES market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.6 Tyrosinemia
    • 7.6.1 Tyrosinemia market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.7 MSUD
    • 7.7.1 MSUD market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.8 Homocystinuria
    • 7.8.1 Homocystinuria market estimates and forecasts, 2016 - 2030 (USD Million)
  • 7.9 Others
    • 7.9.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 8 Medical Foods for Orphan Diseases Market: Sales Channel Estimates & Trend Analysis

  • 8.1 Definitions & Scope
  • 8.2 Global Medical Foods for Orphan Diseases Market: Sales Channel Market Share Analysis, 2022 and 2030
  • 8.3 Online sales
    • 8.3.1 Online sales market estimates and forecasts, 2016 - 2030 (USD Million)
  • 8.4 Institutional sales
    • 8.4.1 Institutional sales market estimates and forecasts, 2016 - 2030 (USD Million)
  • 8.5 Retail sales
    • 8.5.1 Retail sales market estimates and forecasts, 2016 - 2030 (USD Million)

Chapter 9 Medical Foods for Orphan Diseases Market: Regional Estimates & Trend Analysis, By Route of Administration, Product, Application, and Sales Channel

  • 9.1 Global Medical Foods for Orphan Diseases Market: Regional Movement Analysis
  • 9.2 North America
    • 9.2.1 North America medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.2 U.K.
      • 9.3.2.1 U.K. medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.3 Germany
      • 9.3.3.1 Germany medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.4 France
      • 9.3.4.1 France medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.5 Spain
      • 9.3.5.1 Spain medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.6 Italy
      • 9.3.6.1 Italy medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.3.7 Russia
      • 9.3.7.1 Russia medical foods for orphan diseases market estimates and forecasts by route of administration, Product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia pacific medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.2 China
      • 9.4.2.1 China medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.3 Japan
      • 9.4.3.1 Japan medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.4 India
      • 9.4.4.1 India medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.5 Australia
      • 9.4.5.1 Australia medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.6 New Zealand
      • 9.4.6.1 New Zealand medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.7 Singapore
      • 9.4.7.1 Singapore medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.4.8 South Korea
      • 9.4.8.1 South Korea medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.5.4 Argentina
      • 9.5.4.1 Argentina medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
  • 9.6 MEA
    • 9.6.1 MEA medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.6.3 Saudi Arabia
      • 9.6.3.1 Saudi Arabia medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)
    • 9.6.4 UAE
      • 9.6.4.1 UAE medical foods for orphan diseases market estimates and forecasts by route of administration, product, application, and sales channel 2016 - 2030 (USD Million)

Chapter 10 Company Profiles

  • 10.1 DANONE
    • 10.1.1 Company overview
    • 10.1.2 Financial performance
    • 10.1.3 Product benchmarking
    • 10.1.4 Strategic initiatives
  • 10.2 NESTLE
    • 10.2.1 Company overview
    • 10.2.2 Financial performance
    • 10.2.3 Product benchmarking
    • 10.2.4 Strategic initiatives
  • 10.3 ABBOTT
    • 10.3.1 Company overview
    • 10.3.2 Financial performance
    • 10.3.3 Product benchmarking
    • 10.3.4 Strategic initiatives
  • 10.4 MEAD JOHNSON & COMPANY, LLC
    • 10.4.1 Company overview
    • 10.4.2 Financial performance
    • 10.4.3 Product benchmarking
    • 10.4.4 Strategic initiatives
  • 10.5 Relief Therapeutics
    • 10.5.1 Company overview
    • 10.5.2 Financial performance
    • 10.5.3 Product benchmarking
    • 10.5.4 Strategic initiatives
  • 10.6 Solace Nutrition
    • 10.6.1 Company overview
    • 10.6.2 Financial performance
    • 10.6.3 Product benchmarking
    • 10.6.4 Strategic initiatives
  • 10.7 Ajinomoto Cambrooke, Inc.
    • 10.7.1 Company overview
    • 10.7.2 Financial performance
    • 10.7.3 Product benchmarking
    • 10.7.4 Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies, /technology disruptors/innovators
  • Table 3 Few examples of the medical foods in the oral form
  • Table 4 Few examples of the products available in powder form
  • Table 5 Few examples of medical foods in the other formulations
  • Table 6 Oral medical foods for orphan diseases market revenue estimates and forecasts, by products, 2016 - 2030 (USD Million)
  • Table 7 Enteral medical foods for orphan diseases market revenue estimates and forecasts, by products, 2016 - 2030 (USD Million)
  • Table 8 North America medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 9 North America medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 10 North America medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 11 North America medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 12 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 13 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 14 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 15 U.S. medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 16 Canada medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 17 Canada medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 18 Canada medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 19 Canada medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 20 Europe medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 21 Europe medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 22 Europe medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 23 Europe medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 24 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 25 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 26 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 27 U.K. medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 28 Germany medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 29 Germany medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 30 Germany medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 31 Germany medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 32 France medical foods for orphan diseases market revenue estimates and forecast, by route of administration, 2016 - 2030 (USD Million)
  • Table 33 France medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 34 France medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 35 France medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 36 Spain medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 37 Spain medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 38 Spain medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 39 Spain medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 40 Italy medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 41 Italy medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 42 Italy medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 43 Italy medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 44 Russia medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 45 Russia medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 46 Russia medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 47 Russia medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 48 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 49 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 50 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 51 Asia Pacific medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 52 Japan medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 53 Japan medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 54 Japan medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 55 Japan medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 56 China medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 57 China medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 58 China medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 59 China medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 60 Australia medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 61 Australia medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 62 Australia medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 63 Australia medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 64 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 65 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 66 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 67 New Zealand medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 68 India medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 69 India medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 70 India medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 71 India medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 72 South Korea medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 73 South Korea medical foods for orphan diseases market revenue estimates and forecast, by product, 2016 - 2030 (USD Million)
  • Table 74 South Korea medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 75 South Korea medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 76 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 77 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 78 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 79 Singapore medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 80 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 81 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 82 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 83 Latin America medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 84 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 85 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 86 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 87 Brazil medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 88 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 89 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 90 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 91 Mexico medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 92 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 93 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 94 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 95 Argentina medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 96 MEA medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 97 MEA medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 98 MEA medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 99 MEA medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 100 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 101 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 102 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 103 South Africa medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 104 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 105 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 106 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 107 Saudi Arabia medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 108 UAE medical foods for orphan diseases market revenue estimates and forecasts, by route of administration, 2016 - 2030 (USD Million)
  • Table 109 UAE medical foods for orphan diseases market revenue estimates and forecasts, by product, 2016 - 2030 (USD Million)
  • Table 110 UAE medical foods for orphan diseases market revenue estimates and forecasts, by application, 2016 - 2030 (USD Million)
  • Table 111 UAE medical foods for orphan diseases market revenue estimates and forecasts, by sales channel, 2016 - 2030 (USD Million)
  • Table 112 List of other players

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Medical foods for orphan diseases market snapshot, 2022 (USD Million)
  • Fig. 5 Medical foods for orphan diseases market dynamics
  • Fig. 6 Medical foods for orphan diseases market segmentation
  • Fig. 7 Penetration & growth prospects mapping
  • Fig. 8 Technology timeline
  • Fig. 9 Medical foods for orphan diseases market driver impact
  • Fig. 10 Medical foods for orphan diseases market restraints impact
  • Fig. 11 Competition categorization
  • Fig. 12 Key company market share analysis (%)
  • Fig. 13 Company market position analysis
  • Fig. 16 Medical foods for orphan diseases market: Route of administration market share analysis, 2022
  • Fig. 17 Segment Dashboard
  • Fig. 18 Oral medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 19 Enteral medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 20 Medical foods for orphan diseases market: Product market share analysis, 2022
  • Fig. 21 Segment Dashboard
  • Fig. 22 Medical foods for orphan diseases market estimates and forecasts for pills formulation, 2016 - 2030 (USD Million)
  • Fig. 23 Medical foods for orphan diseases market estimates and forecasts for powder formulation, 2016 - 2030 (USD Million)
  • Fig. 24 Medical foods for orphan diseases market estimates and forecasts for liquid formulation, 2016 - 2030 (USD Million)
  • Fig. 25 Medical foods for orphan diseases market estimates and forecasts for other formulations, 2016 - 2030 (USD Million)
  • Fig. 26 Medical foods for orphan diseases market: Application market share analysis, 2022
  • Fig. 27 Segment Dashboard
  • Fig. 29 Medical foods for orphan diseases market estimates and forecasts for phenylketonuria, 2016 - 2030 (USD Million)
  • Fig. 30 Medical foods for orphan diseases market estimates and forecasts for eosinophilic esophagitis, 2016 - 2030 (USD Million)
  • Fig. 31 Medical foods for orphan diseases market estimates and forecasts for FPIES, 2016 - 2030 (USD Million)
  • Fig. 32 Medical foods for orphan diseases market estimates and forecasts for MSUD, 2016 - 2030 (USD Million)
  • Fig. 33 Medical foods for orphan diseases market estimates and forecasts for Homocystinuria, 2016 - 2030 (USD Million)
  • Fig. 34 Medical foods for orphan diseases market estimates and forecasts for other diseases, 2016 - 2030 (USD Million)
  • Fig. 35 Medical foods for orphan diseases market: Sales channel market share analysis, 2022
  • Fig. 36 Medical foods for orphan diseases market estimates and forecasts for online sales channel, 2016 - 2030 (USD Million)
  • Fig. 37 Medical foods for orphan diseases market estimates and forecasts for retail sales channel, 2016 - 2030 (USD Million)
  • Fig. 38 Medical foods for orphan diseases market estimates and forecasts for institutional sales channel, 2016 - 2030 (USD Million)
  • Fig. 39 Regional market snapshot, 2022 & 2030, (USD Million)
  • Fig. 40 Medical foods for orphan diseases market: Regional market share analysis, 2022
  • Fig. 41 North America medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 42 Europe medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 43 Asia Pacific medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 44 Latin America medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 45 MEA medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 46 North America market share, by country, 2016 - 2030 (USD Million)
  • Fig. 47 U.S. medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 48 Canada medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 49 Europe market share, by country, 2016 - 2030 (USD Million)
  • Fig. 50 U.K. medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 51 Germany medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 52 France medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 53 Spain medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 54 Italy medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 55 Russia medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market share, by country, 2016 - 2030 (USD Million)
  • Fig. 57 Japan medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 58 China medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 59 Australia medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 60 New Zealand medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 61 India medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 62 South Korea medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 63 Singapore medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 64 Latin America market share, by country, 2016 - 2030 (USD Million)
  • Fig. 65 Brazil medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 66 Mexico medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 67 Argentina medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 68 MEA market share, by country, 2016 - 2030 (USD Million)
  • Fig. 69 South Africa medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)
  • Fig. 71 UAE medical foods for orphan diseases market estimates and forecasts, 2016 - 2030 (USD Million)